C12Y 205/01078
6,7-dimethyl-8-ribityllumazine synthase
Official title: 6,7-Dimethyl-8-ribityllumazine synthase (2.5.1.78)
C12Y205/01078 (6,7-dimethyl-8-ribityllumazine synthase) appears on 7 US grants and 18 published applications in this corpus.
Search patents in C12Y- Granted patents
- 7
- Published applications
- 18
- Assignees
- 20
- Inventors
- 62
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 2 |
| 2021 | 0 | 1 |
| 2022 | 2 | 2 |
| 2023 | 0 | 1 |
| 2024 | 2 | 5 |
| 2025 | 1 | 2 |
| 2026 | 1 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Limosilactobacillus reuteri strain with high riboflavin production and uses thereof7 Jul 2026US 12,674,188 B2Universiteit Antwerpen
- Nanoparticle platform for antibody and vaccine delivery4 Feb 2025US 12,214,052 B2The Governing Council of the University of Toronto
- HIV-1 Env fusion peptide nanoparticle carrier conjugates and their use6 Aug 2024US 12,053,519 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Glycan-masked engineered outer domains of HIV-1 gp120 and their use6 Aug 2024US 12,053,520 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Engineered outer domain (eOD) of HIV GP120, mutants and use thereof15 Feb 2022US 11,248,027 B2International AIDS Vaccine Initiative
- Influenza ehead immunogens1 Oct 2026US 2026/0295029 A1The Scripps Research Institute
- Coronavirus s2 immunogens1 Oct 2026US 2026/0295034 A1The Scripps Research Institute
- Treatment of atopic dermatitis using self-replicating rna expressing il-3120 Aug 2026US 2026/0240967 A1Ceva Sante Animale
- Pfcsp-based immunogens and related composition and methods31 Jul 2025US 2025/0242008 A1Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
- Nanoparticle platform for antibody and vaccine delivery10 Apr 2025US 2025/0114475 A1The Governing Council of the University of Toronto
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.